Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-24-000064
Filing Date
2024-06-07
Accepted
2024-06-07 17:01:38
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1717794089.html 4  
1 FORM 4 wk-form4_1717794089.xml 4 6659
  Complete submission text file 0001651308-24-000064.txt   8198
Mailing Address PFIZER INC. ATTN. CORP. SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017
Business Address
BRANDICOURT OLIVIER (Reporting) CIK: 0001508518 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 241030501

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)